Strategies in the fight against Parkinson's psychosis

Parkinson's disease, often only associated with the typical motor symptoms such as tremors and lack of movement, reveals a far more complex and stressful facet upon closer inspection. Psychotic symptoms, such as delusions and visual hallucinations, often occur in Parkinson's patients and represent an immense burden for those affected and their relatives. While acoustic hallucinations dominate in schizophrenia, in Parkinson's it is usually visual hallucinations that frighten the patients .
App and nurses accompany you in everyday life
ParkinsonGo TM combines precise gait analysis and a smartphone app with intensive support from Parkinson Telenurses. The aim is to slow down the progression of the disease, maintain mobility and independence and thereby improve the quality of life of those affected. Using sensors attached to the shoes, the ParkinsonGo app analyzes gait quality and records symptom patterns (e.g. poor mobility) as well as everyday challenges in a diary. Intelligent algorithms derive personalized recommendations for action in the form of physiotherapeutic exercise plans and tips for dealing with the disease.

Propionate Supplements and Parkinson's: New Research

In order to improve mobility and safety in everyday life, the medical technology company Portabiles HealthCare Technologies has developed the hybrid care model ParkinsonGo TM together with neurologists and patients. ParkinsonGo TM has been successfully tested and has been reimbursed by several health insurance companies in Germany since January 2024.

App and nurses accompany you in everyday life
ParkinsonGo TM combines precise gait analysis and a smartphone app with intensive support from Parkinson Telenurses. The aim is to slow down the progression of the disease, maintain mobility and independence and thereby improve the quality of life of those affected. Using sensors attached to the shoes, the ParkinsonGo app analyzes gait quality and records symptom patterns (e.g. poor mobility) as well as everyday challenges in a diary. Intelligent algorithms derive personalized recommendations for action in the form of physiotherapeutic exercise plans and tips for dealing with the disease.

ParkinsonGo TM: Novel care model with innovative digital components

In order to improve mobility and safety in everyday life, the medical technology company Portabiles HealthCare Technologies has developed the hybrid care model ParkinsonGo TM together with neurologists and patients. ParkinsonGo TM has been successfully tested and has been reimbursed by several health insurance companies in Germany since January 2024.

App and nurses accompany you in everyday life
ParkinsonGo TM combines precise gait analysis and a smartphone app with intensive support from Parkinson Telenurses. The aim is to slow down the progression of the disease, maintain mobility and independence and thereby improve the quality of life of those affected. Using sensors attached to the shoes, the ParkinsonGo app analyzes gait quality and records symptom patterns (e.g. poor mobility) as well as everyday challenges in a diary. Intelligent algorithms derive personalized recommendations for action in the form of physiotherapeutic exercise plans and tips for dealing with the disease.

Parkinson Network Southern Lower Saxony

Parkinson's networks play a special role in Germany's healthcare system by offering specialized and coordinated care for people with Parkinson's. These networks differ in their structure in Germany and are oriented towards regional needs and bottlenecks in health care. In general, they are aimed at promoting interdisciplinary collaboration between different healthcare providers in order to improve the quality of treatment and the quality of life of those affected. Oh man

Can prasinezumab slow the progression of motor symptoms?

An article originally published in the Ärzteblatt is about the effect of the drug prasinezumab on motor symptoms. In a clinical trial, it was observed that the placebo group experienced a major worsening of their symptoms by 12,29 points. In the group treated with prasinezumab, this deterioration was significantly reduced - to just 4,39 points

Diagnosis of Parkinson's and the correct initial therapy

Parkinson's is a neurological disease that affects the lives of millions of people worldwide, whether directly as sufferers or indirectly as relatives, carers or medical professionals. In this talk, we will strive to provide a comprehensive picture of Parkinson's, from the basics of the disease to current research and proven treatments.
Whether you are already familiar with Parkinson's or are new to the topic, I hope this talk provides you with valuable insights and helps you develop a deeper understanding of the Parkinson's world.
So, without any further delay, let’s dive in and learn more about this fascinating and important condition.

Introduction to the world of Parkinson's - a lecture by Prof. Dr. Ceballos Baumann

Parkinson's is a neurological disease that affects the lives of millions of people worldwide, whether directly as sufferers or indirectly as relatives, carers or medical professionals. In this talk, we will strive to provide a comprehensive picture of Parkinson's, from the basics of the disease to current research and proven treatments.
Whether you are already familiar with Parkinson's or are new to the topic, I hope this talk provides you with valuable insights and helps you develop a deeper understanding of the Parkinson's world.
So, without any further delay, let’s dive in and learn more about this fascinating and important condition.

The hope for a new era in Parkinson's treatment: CDNF in focus

The world of medicine may be on the verge of a revolutionary development in the fight against Parkinson's disease, thanks to the discovery and research surrounding a special protein known as Cerebral Dopamine Neurotrophic Factor (CDNF). This development could not only improve the living standards of millions of those affected, but also offer a new way to treat neurodegenerative diseases.

The skin as a mirror of the brain

We all know the skin as the largest organ in our body - it protects us, regulates temperature and enables touch. But did you know that the skin can now also provide insights into the interior of our nervous system? Boston researchers have found that a protein called phosphorylated alpha-synuclein, which plays a key role in Parkinson's disease and other neurodegenerative diseases, can also be detected in the skin. This exciting discovery opens new avenues for diagnosing Parkinson's and related diseases.

Detect Parkinson's early, delay it, stop it or prevent it

In his lecture “Detect, delay, stop or prevent Parkinson’s disease early” Professor Oertel shares his extensive knowledge and many years of experience with us. Parkinson's disease, a progressive neurodegenerative disease, affects millions of people worldwide. Despite intensive research and development in treatment, it remains a major challenge for patients, families and healthcare professionals.

Professor Oertel will walk us through the latest findings that not only aim to detect the disease in its earliest stages, but also present strategies and therapies that can delay or even stop its progression. He will also discuss preventative measures that could reduce the risk of developing Parkinson's disease.

This lecture is aimed at anyone interested in Parkinson's disease and its impact on the lives of those affected. Prepare for an insightful session that will shed light on the darkness of this disease and offer hope for new avenues in its treatment and prevention.